URBANA, Ill. and SALT LAKE CITY, April 14, 2020 /PRNewswire/ — Carle Health today joined Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in announcing a five year, multi-million dollar strategic partnership to improve the quality of patient care, lower costs and meet the changing needs of patients, providers and payors in today’s rapidly evolving healthcare marketplace.
Through this partnership, Health Catalyst will provide data and analytics solutions to measure quality and cost of care, allow for increased and efficient sharing of analytics, and provide a comparative analytics platform to help increase learnings about costs, outcomes, and trending best practices. The solutions will support Carle Health, which includes: Carle Foundation Hospital; Carle Hoopeston Regional Health Center; Carle Richland Memorial Hospital; Carle Physician Group, with more than 1,000 doctors and advanced practice providers; as well as Health Alliance, a leading provider-driven health plan serving Illinois, Iowa, Indiana, Ohio and Washington.
“This strategic partnership with Health Catalyst will strengthen our ability to deliver on our mission of serving people through high-quality care, medical research and education,” said James C. Leonard, MD, President and CEO of Carle Health. “Through our rigorous selection process, Health Catalyst ascended as the best partner because, beyond their superior data, analytics and services capabilities, they share a strong cultural commitment to the values we most cherish: integrity, collaboration, accountability, respect, and excellence.”
“We have great admiration for Carle and are honored to have the opportunity to forge this critical partnership,” said Dan Burton, CEO of Health Catalyst. “We are excited about combining our Solution with Carle’s exceptional people, who have tremendous experience and know-how. We believe that together we will improve the organization’s clinical, financial and operational outcomes.”
This agreement will use Health Catalyst’s open, scalable Data Operating System (DOS™) platform designed to meet three missions of data—analytics, application development, and interoperability—in a single, common architectural platform that maximizes the value of data. DOS’s hybrid approach combines healthcare data expertise and data management tools that support internal innovation, enabling data consumption from across the enterprise, integration with data from hundreds of sources, and delivery of enriched data sets to external customers. Flexible, closed-loop analytics make it easier for transactional customers to understand outcomes and costs and identify improvement opportunities. Carle will also immediately have access to Health Catalyst’s growing suite of COVID-19 solutions, including but not limited to a registry, staff and patient tracker and capacity planning tool.
“Successfully bringing healthcare data together to drive broad-based improvement is particularly challenging because of the complexity and data silos that make up the data backbone of the modern healthcare system,” said Matthew Kolb, Executive Vice President and Chief Operating Officer of Carle Health. “Carle believes in the potential of Health Catalyst’s data, analytics and service capabilities to support the creation of a unified approach that will connect more than fifty currently disparate data sources, one of which is our EHR, into a single analytics platform. This partnership will enhance our understanding of improvement opportunities.”
Tom Burton, Co-Founder and Chief Learning Officer at Health Catalyst said, “The Data Operating System Platform, along with our application suites and improvement expertise, combine to help identify and eliminate inefficiency and reduce unwarranted variation, helping our clients save millions of dollars and provide higher value care. We look forward to seeing the talented team at Carle leverage our solutions to benefit the patients they serve.”
About Carle Health
Carle Health combines clinical care, health insurance, research and academics in a way that solves real-world problems today with an eye toward the future. Based in Urbana, IL, Carle is vertically integrated with 8,000 employees, including more than 1,000 doctors and advanced practice providers. Its hospitals, physician group, health plan and associated healthcare businesses include the Carle Illinois College of Medicine, the world’s first engineering-based medical school and Health Alliance, a leading provider-driven health plan serving Illinois, Iowa, Indiana, Ohio and Washington. Carle is dedicated to doing what it takes to make life better for as many as possible through its mission to serve people through high-quality care, medical research and education.
About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.
View original content to download multimedia:http://www.prnewswire.com/news-releases/health-catalyst-and-carle-health-partner-to-improve-patient-care-with-data-and-analytics-solutions-301039866.html
SOURCE Health Catalyst
Presenting a New Innovation in the Field of Spinal Rehabilitation at Physiowell DubaiDUBAI, ARAB EMIRATES…
SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare…
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had…
Pemvidutide elicited significant weight loss and decreases in pro-inflammatory serum lipids associated with atherogenesis and…
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…